Zentalis Pharmaceuticals, Inc. short interest in 2023
In 2023, Zentalis Pharmaceuticals, Inc.'s disclosed short interest ran from 13.79% of shares outstanding on 13 Jan 2023 to 18.01% on 29 Dec 2023, a change of +4.22 percentage points. The year's high was 24.41% on 30 Jun 2023 and its low 13.16% on 31 Jan 2023, averaging 16.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 36.92 days on 14 Jul 2023. Full history: Zentalis Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 13.79% (13 Jan 2023)
- End of year
- 18.01% (29 Dec 2023)
- Change
- +4.22 pp
- High
- 24.41% (30 Jun 2023)
- Low
- 13.16% (31 Jan 2023)
- Average
- 16.99%
- Highest days to cover
- 36.92 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 13.79% | 9.70 | |
| 31 Jan 2023 | 13.16% | 17.89 | |
| 15 Feb 2023 | 13.86% | 14.77 | |
| 28 Feb 2023 | 13.47% | 17.03 | |
| 15 Mar 2023 | 13.59% | 17.67 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 14.97% | 12.66 | |
| 14 Apr 2023 | 15.16% | 17.27 | |
| 28 Apr 2023 | 16.55% | 15.34 | |
| 15 May 2023 | 17.88% | 11.90 | 10-Q filed, results (8-K) |
| 31 May 2023 | 20.70% | 8.24 | |
| 15 Jun 2023 | 22.33% | 11.28 | |
| 30 Jun 2023 | 24.41% | 12.49 | |
| 14 Jul 2023 | 23.09% | 36.92 | |
| 31 Jul 2023 | 22.42% | 32.55 | |
| 15 Aug 2023 | 17.54% | 26.73 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 17.00% | 31.63 | |
| 15 Sep 2023 | 16.00% | 15.78 | |
| 29 Sep 2023 | 15.97% | 12.83 | |
| 13 Oct 2023 | 15.16% | 12.39 | |
| 31 Oct 2023 | 15.78% | 13.02 | |
| 15 Nov 2023 | 14.95% | 4.50 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 15.68% | 21.09 | |
| 15 Dec 2023 | 16.38% | 10.23 | |
| 29 Dec 2023 | 18.01% | 14.14 |
See also: Zentalis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.